Introduction
============

Vascular endothelial cells (ECs) are known serve an important in the entire cardiovascular system ([@b1-ijmm-44-02-0457],[@b2-ijmm-44-02-0457]), and they have anticoagulation and anti-adhesive effects. All stimulating factors can activate vascular ECs and cause cell injury. The injury of vascular ECs by oxidative stress is a major initiator and driving factor in the progression of atherosclerosis ([@b3-ijmm-44-02-0457],[@b4-ijmm-44-02-0457]). Therefore, in anti-atherosclerotic treatment, it is key is to reduce the injury and loss of vascular ECs. Studies have indicated that the major type of injury from oxidative damage is apoptosis, which may affect the natural function and structure of vascular ECs, and result in the loss of vascular ECs ([@b4-ijmm-44-02-0457]).

Autophagy is a lysosome-dependent catabolic process involving the degradation of long-lived proteins and organelles, and recycling of cytoplasmic components ([@b5-ijmm-44-02-0457],[@b6-ijmm-44-02-0457]). It is known that autophagy has a crucial role in maintaining cardiovascular cell functions and structure, and to degrade long-lived proteins and their own organelles ([@b7-ijmm-44-02-0457]). It has been indicated that autophagy serves a vital role in cardiovascular disease by regulating EC functions ([@b8-ijmm-44-02-0457]).

Salvianolic acid B (Sal B) is the most abundant water-soluble compound extracted from Danshen and possesses anti-oxidative and anti-inflammatory effects. Its chemical structure is presented in [Fig. 1](#f1-ijmm-44-02-0457){ref-type="fig"}. The Chinese medicinal formulation \'Shuangdan oral solution\' is used to treat atherosclerosis and one of its major components is Sal B ([@b9-ijmm-44-02-0457]); however, the mechanisms of action remain to be fully elucidated. Therefore, the present study further examined the anti-atherosclerotic effects of Sal B and investigated the underlying mechanisms. Previous studies have confirmed that Sal B has anti-oxidative effects and eliminates superoxide anion radicals (O^2−^), thereby suppressing hydrogen peroxide (H~2~O~2~)-induced apoptosis ([@b10-ijmm-44-02-0457],[@b11-ijmm-44-02-0457]). Another study indicated that Sal B promotes human umbilical vein endothelial cell (HUVEC) proliferation ([@b12-ijmm-44-02-0457]). However, the mechanisms, including whether autophagy is involved, remain to be fully elucidated. Autophagy and apoptosis are crucial mechanisms in regulating cell survival ([@b13-ijmm-44-02-0457]). The possible association between autophagy and apoptosis in the effects of Sal B also remains to be determined. Therefore, the present study aimed to investigate the protective effects of Sal B against H~2~O~2~-induced apoptosis in HUVECs and the underlying mechanisms in order to provide novel approaches for the treatment of atherosclerosis.

Materials and methods
=====================

Reagents and antibodies
-----------------------

The HUVECs were provided by the Cell Bank of the Chinese Academy of Sciences. Dulbecco\'s modified Eagle\'s medium (DMEM) was obtained from Gibco/Invitrogen; Thermo Fisher Scientific, Inc. (Waltham, MA, USA). The MTT kit was purchased from Beyotime Institute of Biotechnology. Hoechst 33258, the Caspase 3 Activity Assay kit, adenovirus (Ad)-mCherry-green fluorescence protein (GFP)-light chain (LC)3B and the bicin-choninic acid (BCA) Protein Assay kit were all purchased from Beyotime Institute of Biotechnology. Antibodies against p62 (cat. no. ab109012; 1:10,000), LC3-II (cat. no. ab192890; 1:2,000), AMPK (cat. no. ab32047; 1:1,000), phosphorylated (p)-AMPK (cat. no. ab131357; 1:500), cytochrome *c* (cat. no. ab133504; 1:5,000), AKT (cat. no. ab179463; 1:10,000), p-AKT (cat. no. ab81283; 1:5,000), caspase 3 (cat. no. ab32351; 1:5,000), mammalian target of rapamycin (mTOR; cat. no. ab32028; 1:1,000) and p-mTOR (cat. no. ab109268; 1:1,000) were purchased from Abcam (Cambridge, MA, USA), and antibody against Beclin-1 (cat. no. 3495T; 1:1,000) was obtained from Cell Signaling Technology, Inc. (Danvers, MA, USA). β-actin (cat. no. bs-0061R; 1:5,000) and goat anti-mouse IgG (cat. no. bs-0295GS; 1:2,000) were obtained from Bioss Biotechnology (Beijing, China). 3-Methyladenine (3-MA) (Selleck, Houston, TX, USA) was used to inhibit autophagy the and mTOR inhibitor, rapamycin (Selleck, Houston, TX, USA), was used to activate autophagy. Compound C was purchased from Calbiochem (VWR, Lutterworth, UK).

Cell culture
------------

The HUVECs were grown in DMEM supplemented with 10% fetal bovine serum (GIBCO/Invitrogen; Thermo Fisher Scientific, Inc.) in an incubator at 37°C and in a humidified atmosphere with 5% CO~2~. The HUVECs were pre-treated with Sal B (5, 10 or 20 *µ*g/ml) for 24 h, following which the liquids were removed and H~2~O~2~ (800 *µ*M) was added for 24 h at 37°C.

Cell viability assay
--------------------

An MTT assay was used to assess the cell viability, as described previously ([@b14-ijmm-44-02-0457]). The HUVECs were cultured in 96-well plates (5,000 per well) and incubated at 37°C for 12 h. Following the different treatments, 10 ml MTT solution at a 1:10 dilution was added to each well, followed by incubation at 37°C for 40 min. The absorbance at 450 nm was detected with a microplate reader (Bio-Rad 550; Bio-Rad Laboratories, Inc.). The optical density (OD) was used to determine the percentage of viable cells via the following formula: Cell viability (%)=(OD~treatment\ group~-OD~blank\ group~/OD~control\ group~-OD~blank\ group~) ×100%.

Hoechst 33258 fluorescence staining
-----------------------------------

The HUVECs received the same treatments as described above, followed by a wash with PBS and fixing with 0.5 ml 4% paraformal-dehyde for 15 min. Following rinsing twice with PBS, the cells were stained with 0.5 ml Hoechst 33258 (5 mg/ml) for 15 min and examined under a fluorescence microscope. HUVECs exhibited a normal nuclear size and uniform fluorescence, whereas apoptotic cells membrane exhibited increased permeability, chromatin shrinkage and denser apoptotic nuclei.

Flow cytometric analysis
------------------------

An Annexin V-FITC/propidium iodide (PI) dual staining detection kit was used to detect apoptosis in compliance with the manufacturer\'s protocols. Following treatment, the HUVECs were washed twice in cold PBS, and the cells were then stained with Annexin V-FITC and PI in binding buffer for 15 min at room temperature in the dark. The cells were subsequently examined by flow cytometry.

Caspase-3 activity assay
------------------------

The activity of caspase-3 was measured using the caspase-3 activity kit (Beyotime Institute of Biotechnology). Cellular extracts (50 *µ*l) were incubated in a 96-well microtiter plate with 2 mM Ac-DEVD-pNA, a substrate of active caspase-3, for 2 h at 37°C. Caspase activity was measured by cleavage of the Ac-DEVD-pNA substrate to pNA ([@b15-ijmm-44-02-0457]). The absorbance at 405 nm was measured by an ELISA reader at room temperature.

mCherry-GFP-LC3B
----------------

The cells were transfected with Ad-mCherry-GFP-LC3B under non-autophagic conditions, following which the mCherry-GFP-LC3B was present in the cytoplasm, as indicated by dispersive yellow fluorescence. Under conditions of autophagy, mCherry-GFP-LC3B is aggregated on the autophagic membrane, visualized as yellow spots. When the autophagosome is fused with lysosomes, the fluorescence of GFP is quenched, with the reagent presents as red spots. The cells were washed twice with PBS, followed by the addition of 1.5 ml fresh medium and transfected with Ad-mCherry-GFP-LC3B adenovirus (Beyotime Institute of Biotechnology), which adopts a mature E1 defective recombinant adenovirus vector system and expresses the fusion protein of red fluorescent protein mCherry, GFP and LC3B in target cells after infection at a MOI of 20 at 37°C for 24 h. Following Sal B and H~2~O~2~ treatment, the variations in LC3B fluorescence were recorded with a fluorescence microscope.

Western blot analysis
---------------------

The levels of p62, LC3-II, AMPK and p-AMPK, cytochrome *c*, AKT, p-AKT, cleaved caspase-3, mTOR and p-mTOR in protein extracts from the HUVECs were detected by western blot analysis. The cells were lysed at 4°C for 30 min with RIPA lysis buffer (Beyotime Institute of Biotechnology) containing protease and phosphatase inhibitors, and soluble lysates were harvested via centrifugation at 168 × g for 20 min at 4°C and boiled, and protein concentration was determined with the BCA kit. The protein samples (7 *µ*l per lane) were fractionated by SDS-PAGE, the percentage of which was decided by the type of protein. LC3 was used with a 15% separation gel and the other proteins were used with a 12% separation gel. Transferred onto a polyvinylidene difluoride membrane (Merck KGaA, Darmstadt, Germany) and then blocked in 5% skimmed milk powder. The membranes were incubated with primary antibodies for 24 h and secondary antibody for 1 h at room temperature. Following washing with tris buffered saline containing 0.1% Tween-20, the enhanced chemiluminescence western blotting substrate (Merck KGaA) was added to the membranes, which were evaluated using a gel imaging system (Bio-Rad Laboratories, Inc.). The analysis of each protein was performed three times.

Statistical analyses
--------------------

Data are expressed as the mean ± standard error of mean. SPSS statistical software (version 17.0; SPSS, Inc., Chicago, IL, USA.) was used for statistical analyses. One-way ANOVA was used for comparison between multiple groups, followed by the Bonferroni post hoc test or unpaired Student\'s t-test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

Sal B protects HUVECs from H~2~O~2~-induced cytotoxicity
--------------------------------------------------------

First, the HUVECs were treated with different concentrations of H~2~O~2~ for 24 h to determine the dose to achieve optimal oxidative stress conditions. The cell viability in the different groups was detected using an MTT assay. As presented in [Fig. 2A](#f2-ijmm-44-02-0457){ref-type="fig"}, an H~2~O~2~ dose-dependent increase in cytotoxicity was observed. The cell viabilities were significantly decreased following treatment with 1,000 *µ*M H~2~O~2~. Therefore, 800 *µ*M H~2~O~2~ was selected to perform the subsequent experiments. In order to determine the concentration range of Sal B to assess its cyto-protective effect, the HUVECs were first treated with this drug at different concentrations (5, 10, 20, 40 and 80 *µ*g/ml). When the concentration was increased to 80 *µ*g/ml, the cell viability was significantly decreased ([Fig. 2B](#f2-ijmm-44-02-0457){ref-type="fig"}). Therefore, Sal B was used at the concentrations of 5, 10 and 20 *µ*g/ml in the subsequent experiments. To assess the cytoprotective effect of Sal B, the HUVECs were pre-treated with different concentrations of Sal B (5, 10 and 20 *µ*g/ml) for 24 h, followed by incubation with 800 *µ*M H~2~O~2~ for 24 h. As presented in [Fig. 2C](#f2-ijmm-44-02-0457){ref-type="fig"}, the cell viability in the Sal B + H~2~O~2~ group was increased compared with that in the H~2~O~2~ group, suggesting that Sal B protects HUVECs against H~2~O~2~-induced damage.

Sal B inhibits apoptosis in HUVECs induced by H~2~O~2~
------------------------------------------------------

To determine whether the effect of Sal B to inhibit the toxicity of H~2~O~2~ to HUVECs was associated with inhibition of inhibition of cell injury and apoptosis *in vitro*, the HUVECs were pre-treated with different concentrations of Sal B (5, 10 or 20 *µ*g/ml) for 24 h, followed by H~2~O~2~ treatment for 24 h. The Hoechst staining assay is capable of detecting condensed chromatin in apoptotic cells ([@b16-ijmm-44-02-0457]). The Hoechst staining results ([Fig. 3A](#f3-ijmm-44-02-0457){ref-type="fig"}) indicated that the proportion of apoptotic cells was significantly increased in the H~2~O~2~ treatment group compared with that in the control group, but this was attenuated by pre-treatment with Sal B ([Fig. 3C](#f3-ijmm-44-02-0457){ref-type="fig"}). To further confirm this observation, flow cytometry with Annexin V-FITC/PI double staining was performed. In accordance with the results of the Hoechst staining assay, Annexin V-FITC/PI double staining indicated a similar increase in cell apoptosis in the H~2~O~2~ group compared with that in the control group. However, a dose-dependent decrease in the apoptotic rate of the HUVECs was achieved by pre-treatment with Sal B ([Fig. 3C and D](#f3-ijmm-44-02-0457){ref-type="fig"}). In addition, the activity of caspase-3, a key enzyme in the apoptotic process, was detected. The H~2~O~2~-induced increase in the activity of caspase-3 was attenuated by pre-treatment with Sal B ([Fig. 3H](#f3-ijmm-44-02-0457){ref-type="fig"}). Furthermore, the levels of apoptosis-associated proteins cytochrome c and cleaved caspase-3 were detected by western blotting. The results indicated that pre-treatment with Sal B decreased the H~2~O~2~-induced cytoplasmic levels of cytochrome *c* and cleaved caspase-3 in the HUVECs ([Fig. 3E-G](#f3-ijmm-44-02-0457){ref-type="fig"}). These results all demonstrated that Sal B protects HUVECs from oxidative stress-induced apoptosis *in vitro*.

Autophagy protects HUVECs against H~2~O~2~-induced apoptosis
------------------------------------------------------------

An increasing number of studies have suggested that an appropriate level of autophagy may protect cells against cell injury ([@b17-ijmm-44-02-0457]). To determine whether autophagy protects HUVECs from apoptosis under oxidative stress, the autophagy inhibitor 3-MA and the mTOR inhibitor rapamycin were used. First, upregulation of LC3-II (autophagy-associated protein) and downregulation of p62 were observed following stimulation by H~2~O~2~ in comparison with the control group, and these changes were abrogated by 3-MA but enhanced by rapamycin ([Fig. 4D-F](#f4-ijmm-44-02-0457){ref-type="fig"}). These results suggest that autophagy was induced in this cell model of oxidative stress. Regarding the effect of autophagy on cell viability, it was observed that the viability in the H~2~O~2~ group was decreased compared with that in the control group, whereas rapamycin increased cell viability and 3-MA decreased cell viability compared with that in the H~2~O~2~ group ([Fig. 4A](#f4-ijmm-44-02-0457){ref-type="fig"}). Flow cytometric analysis was then performed for further confirmation, and the results indicated that apoptosis in the rapamycin group was decreased, whereas that in the 3-MA group was increased, compared with that in the H~2~O~2~ group ([Fig. 4B and C](#f4-ijmm-44-02-0457){ref-type="fig"}), further suggesting that autophagy may inhibit apoptosis.

In addition, apoptosis-associated proteins were determined for further confirmation, and the results indicated that, compared with those in the H~2~O~2~ group, rapamycin decreased the protein levels of cytochrome *c* and cleaved caspase-3, whereas 3-MA enhanced their levels ([Fig. 4G-I](#f4-ijmm-44-02-0457){ref-type="fig"}). These results suggest that autophagy is a protective mechanism against H~2~O~2~-induced HUVEC apoptosis.

Sal B promotes autophagy in HUVECs under oxidative stress
---------------------------------------------------------

The HUVECs were transfected with Ad-mCherry-GFP-LC3B followed by challenge with H~2~O~2~ with pretreatment of 20 *µ*g/ml Sal B. The numbers of green, red and yellow spots were increased in the Sal B + H~2~O~2~ group compared with those in the H~2~O~2~ group ([Fig. 5A and B](#f5-ijmm-44-02-0457){ref-type="fig"}). These results suggested that Sal B promotes autophagy flux. To further confirm whether Sal B promotes autophagy in HUVECs under oxidative stress, the HUVECs were pre-treated with different concentrations of Sal B (5, 10 and 20 *µ*g/ml), followed by incubation with 800 *µ*M H~2~O~2~ for 24 h, and the expression levels of LC3-II, Beclin-1 and p62 were detected. The results indicated that LC3-II and Beclin-1 were increased, and p62 was decreased by H~2~O~2~ treatment, and these changes were enhanced by Sal B in a concentration-dependent manner ([Fig. 5C-F](#f5-ijmm-44-02-0457){ref-type="fig"}). Taken together, these results indicate that Sal B enhances autophagy in HUVECs under oxidative stress.

Sal B promotes autophagy to decrease H~2~O~2~-induced apoptosis in HUVECs
-------------------------------------------------------------------------

The HUVECs were pre-treated with different concentrations of Sal B (5, 10 and 20 *µ*g/ml), followed by incubation with 800 *µ*M H~2~O~2~ and optionally with 4 mM 3-MA for 24 h. As presented in [Fig. 6A-C](#f6-ijmm-44-02-0457){ref-type="fig"}, Sal B increased the cell viability and decreased the apoptosis of HUVECs compared with those in the H~2~O~2~ group. However, these effects of Sal B were attenuated by 3-MA, suggesting that Sal B increased autophagy to decrease apoptosis. To confirm this, the apoptosis-associated proteins cytochrome *c* and cleaved-caspase 3, and the autophagy-associated proteins LC3-II and p62 were detected in the above treatment groups. The results indicated that the addition of 3-MA significantly decreased the expression of LC3-II and increased that of p62 in the HUVECs compared with those in the 20 *µ*g/ml Sal B + H~2~O~2~ group ([Fig. 6D-F](#f6-ijmm-44-02-0457){ref-type="fig"}). Furthermore, 3-MA decreased the expression levels of cytochrome *c* and cleaved caspase-3 compared with those in the 20 *µ*g/ml Sal B + H~2~O~2~ group ([Fig. 6G-I](#f6-ijmm-44-02-0457){ref-type="fig"}). These results confirmed that the increased autophagic activity induced by Sal B has a protective effect against H~2~O~2~-induced apoptosis in HUVECs.

Sal B activates cell autophagy through the AMPK/mTOR pathway under oxidative stress
-----------------------------------------------------------------------------------

As autophagy may be induced via several different pathways, the present study aimed to determine which of them is promoted by Sal B via western blot analysis of AKT, p-AKT, AMPK, p-AMPK, mTOR and p-mTOR. As is presented in [Fig. 7A-D](#f7-ijmm-44-02-0457){ref-type="fig"}, treatment with Sal B (5, 10 and 20 *µ*g/ml) followed by incubation with 800 *µ*M H~2~O~2~ decreased the levels of p-AKT and p-mTOR and increased the levels of p-AMPK in a dose-dependent manner compared with those in the control group. In the group pre-treated with Sal B, the expression of p-AMPK was increased and that of p-mTOR was decreased, whereas p-AKT was not significantly affected, compared with the levels in the H~2~O~2~ group. These results indicate that Sal B may promote autophagy via the AMPK/mTOR signaling pathway, rather than the PI3K/AKT/mTOR pathway. To confirm the mechanism of autophagy promoted by Sal B, the AMPK inhibitor compound C was used to determine the resulting effect on the level of p-AMPK. In the group that was co-treated with compound C, the level of p-mTOR was increased and that of p-AMPK was decreased compared with levels in the Sal B + H~2~O~2~ group ([Fig. 7E-G](#f7-ijmm-44-02-0457){ref-type="fig"}), which confirmed AMPK/mTOR signaling as at least part of the underlying molecular mechanism.

Discussion
==========

One of the factors causing atherosclerosis is vascular EC apoptosis, which may be triggered by free radicals, oxidized low-density lipoprotein (ox-LDL) and the activation of blood platelets. Previous studies have indicated that the number of vascular ECs is decreased by apoptosis, and the prevention of endothelial activation and reduction of endothelial injury are key to the prevention and treatment of AS ([@b18-ijmm-44-02-0457]-[@b20-ijmm-44-02-0457]). Therefore, the present study investigated a strategy to inhibit vascular EC apoptosis and thereby prevent atherosclerosis. Numerous studies have confirmed that Sal B has an anti-atherosclerotic effect due to its anti-oxidative and anti-inflammatory actions, and its suppression of the presence of foam cells ([@b21-ijmm-44-02-0457]-[@b25-ijmm-44-02-0457]). Therefore, Sal B exerts a dual effect, namely the protection of vascular ECs and a decrease in the formation of a fibrous cap that stabilizes a plaque, which renders Sal B suitable for treating atherosclerosis, for example, through resolving recurrence by stabilizing plaques or as a co-treatment for enhancing the efficiency of other anti-atherosclerotic treatments. The results of the present study indicate that Sal B inhibited the apoptosis of vascular ECs under oxidative stress. In addition, it was indicated that the induction of autophagy serves an important role in the anti-apoptotic effects of Sal B under oxidative stress. Further mechanistic investigation indicated that Sal B induced autophagy in vascular ECs under oxidative stress by activating the AMPK/mTOR pathway. In *in vitro* experiments, H~2~O~2~ is used as cell injury inducer ([@b26-ijmm-44-02-0457]). In the present study, 800 *µ*M H~2~O~2~ led to the apoptosis of vascular ECs, as the survival rate decreased to 53.02±6.07%. Of note, Sal B suppressed H~2~O~2~-induced apoptosis in HUVECs, suggesting that Sal B has the potential to treat atherosclerosis by preventing vascular EC apoptosis under oxidative stress conditions. Wu *et al* ([@b27-ijmm-44-02-0457]) reported that Sal B protects ECs against oxidative stress-induced cell injury through upregulating glucose-regulated protein 78. Furthermore, Chen *et al* ([@b28-ijmm-44-02-0457]) demonstrated the protective effect of Sal B against ox-LDL-induced HUVEC injury and apoptosis. In line with this, another study confirmed that Sal B protects vascular ECs against injury induced by oxidative stress ([@b29-ijmm-44-02-0457]). These previous studies further support the present observations, and based on these studies, the underlying molecular mechanisms and pathways were then further investigated.

The association between autophagy and apoptosis is a focus of research. Autophagy is an intracellular catabolic process in which long-lived proteins are recycled and damaged organelles are eliminated, and under certain conditions, it also promotes apoptosis ([@b30-ijmm-44-02-0457]). Autophagy has been confirmed to induce apoptosis under high stress conditions ([@b31-ijmm-44-02-0457]). However, autophagy may be tuned to maintain cellular homeostasis under different stresses through the inhibition of apoptosis ([@b32-ijmm-44-02-0457]). Certain studies have indicated that autophagy may have two different effects to either prevent or induce apoptosis, depending on cell function, disease stage, therapeutic schedule and cell micro-environment ([@b33-ijmm-44-02-0457]). It is well-known that autophagy has a vital role in protecting the cardiovascular system ([@b34-ijmm-44-02-0457]). A previous study demonstrated the cardioprotective effect of Sal B on acute myocardial infarction by promoting autophagy and neovascularization and inhibiting apoptosis ([@b35-ijmm-44-02-0457]). It has been shown that autophagy serves to eliminate injured mitochondria when a large number of apoptotic factors are released into the cytoplasm. Therefore, promotion of the autophagy of injured cells may provide a novel anti-atherosclerotic strategy. In the present study, the autophagy inhibitor, 3-MA, and the autophagy inducer, rapamycin, were used to confirm the roles of autophagy in HUVECs. Compared with the control group, treatment of the HUVECs with 3-MA increased apoptosis, decreased autophagy marker LC3-II, and increased the levels of p62 and the apoptosis-associated cytochrome *c* and cleaved-caspase 3 proteins. However, the autophagy inducer rapamycin produced the opposite effect, namely decreasing apoptosis, increasing LC3-II and decreasing the levels of p62, cytochrome c and cleaved caspase-3. This indicated that autophagy has an important role in regulating apoptosis to protect cells.

As the results of the present study indicated that Sal B protects HUVECs against H~2~O~2~-induced cell injury, loss- and gain-of-function experiments were then used to assess the possible involvement of autophagy as an underlying mechanism. Pre-treatment with Sal B followed by incubation with 800 *µ*M H~2~O~2~ resulted in the upregulation of LC3-II and Beclin-1 and the downregulation of p62, in addition to the upregulation of autophagic influx, indicating that autophagy was promoted to protect the cell. However, simultaneous treatment with 3-MA partly eliminated this protective effect by Sal B. Therefore, the promotion of autophagy may be one of the mechanisms by which Sal B prevents apoptosis under oxidative stress. Autophagy is regulated by numerous complex signaling pathways, including AMPK, mTOR and Bcl-2/Beclin-2 ([@b36-ijmm-44-02-0457]). The mTOR signaling pathway serves a crucial role in autophagy ([@b37-ijmm-44-02-0457]); in order to adapt to energy metabolism under stress, AMPK is activated and then inhibits mTOR, inducing the activation of autophagy ([@b38-ijmm-44-02-0457]). mTOR is an energy sensor that is contrary to AMPK ([@b39-ijmm-44-02-0457]), which is suppressed when energy is poor and is activated when energy is abundant. It is situated downstream of pro-growth factors and pro-synthetic metabolic factors ([@b40-ijmm-44-02-0457]). PI3K/Akt/mTOR and AMPK/mTOR signaling have been investigated in numerous studies as autophagy signaling pathways. AKT phosphorylated mTOR to generate activated p-mTOR and triggers downstream signaling to inhibit autophagy. When a cell is under oxidative stress, serine/threonine kinase 11 may lead to the phosphorylation of AMPK. p-AMPK negatively regulates the mTOR signaling pathway to promote autophagy ([@b36-ijmm-44-02-0457]). In the present study, pre-treatment with Sal B significantly increased the level of p-AMPK and decreased the level of p-mTOR, but had no effect on the level of p-AKT. Of note, the AMPK inhibitor, compound C, decreased p-mTOR and increased p-AMPK. In addition, as presented in the chemical structure of Sal B in [Fig. 1](#f1-ijmm-44-02-0457){ref-type="fig"}, the molecule bears hydroxyl groups on a phenol ring that exert potent anti-oxidative effects which is unlike the effect of other activators of autophagy, including rapamycin, which directly combines with mTOR. From the present results, it is evident that Sal B protects HUVECs from oxidative stress via the AMPK/mTOR pathway. Regarding the mechanisms of other autophagy-induced antioxidants, resveratrol acts via the AMPK/Sirtuin 1/autophagy pathway ([@b41-ijmm-44-02-0457]), and curcumin activates autophagy via the PI3K/AKT/mTOR pathway ([@b42-ijmm-44-02-0457]). The results of the present study revealed that Sal B has similarities with and differences from certain other autophagy-inducing antioxidants.

In conclusion, the results of the present study indicate that Sal B has the ability to protect HUVECs from apoptosis by promoting autophagy under oxidative stress, and the promotion of autophagy induced by Sal B is mediated via the upregulated phosphorylation of AMPK and the downregulation of mTOR signaling.
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![Cell viability determination via MTT assay. (A) HUVECs were treated with H~2~O~2~ at the indicated concentrations. (B) HUVECs were incubated with the indicated concentrations of Sal B for 24 h. (C) HUVECs were pretreated with Sal B (5, 10 and 20 *µ*g/ml) for 24 h and then treated with or without H~2~O~2~ (800 *µ*M) for 24 h. The data are representative of three independent experiments (mean ± SEM); ^\*^P\<0.05 and ^\*\*^P\<0.01 compared with the control group, ^\#\#^P\<0.01 compared with the control group. HUVECs, human umbilical vein endothelial cells; Sal B, salvianolic acid B; H~2~O~2~, hydrogen peroxide.](IJMM-44-02-0457-g01){#f2-ijmm-44-02-0457}

###### 

Sal B inhibits H~2~O~2~-induced apoptosis in HUVECs. (A) HUVECs were treated with H~2~O~2~ in the presence or absence Sal B, and the cells were stained with Hoechst 33258 (white arrows indicate apoptotic cells; magnification, ×200). (B) Flow cytometric analysis of HUVEC apoptosis was stained by Annexin Ⅴ-FITC/propidium iodide double staining; (a) control group; (b) H~2~O~2~ group; (c) H~2~O~2~ + 5 *µ*g/ml Sal B group; (d), H~2~O~2~ + 10 *µ*g/ml Sal B group; (e) H~2~O~2~ + 20 *µ*g/ml Sal B group. (C) Rate of apoptosis quantified by Hoechst. (D) Rate of apoptosis quantified by flow cytometry; Sal B decreased apoptosis of the HUVECs induced by H~2~O~2~. Data are representative of three independent experiments (mean ± SEM); ^\#\#^P\<0.01 compared with the control group; ^\*^P\<0.05 and ^\*\*^P\<0.01 compared with the H~2~O~2~ group. (E) Sal B decreased H~2~O~2~ -induced caspase-3 activity. ^\#\#^P\<0.01 compared with the control group; ^\*\*^P\<0.01 compared with the H~2~O~2~ group. (F) HUVECs were incubated with different concentrations (5, 10, 20 *µ*g/ml) of Sal B for 24 h and then stimulated with H~2~O~2~ (800 *µ*M) for 24 h. The protein levels of cytochrome *c* and cleaved caspase-3 or β-actin were determined by western blotting. Bar charts show the quantification of (G) cytochrome *c* and (H) cleaved caspase-3. Relative protein levels are presented as the mean ± SEM of the optical density from three separate experiments. ^\#\#^P\<0.01 compared with control group; ^\*\*^P\<0.01 compared with H~2~O~2~ group. HUVECs, human umbilical vein endothelial cells; Sal B, salvianolic acid B; H~2~O~2~, hydrogen peroxide.
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###### 

Autophagy decreases the apoptosis of HUVECs induced by H~2~O~2~. (A) Rapamycin increased and 3-MA decreased the cell viability of HUVECs induced by H~2~O~2~. (B) Flow cytometric analysis of HUVEC apoptosis with staining by Annexin Ⅴ-FITC/propidium iodide double staining; (a) control group; (b) H~2~O~2~ group; (c) H~2~O~2~ + 3-MA group; (d) H~2~O~2~ + Rapamycin group. (C) Rate of apoptotic cells quantified by flow cytometry; rapamycin decreased and 3-MA increased apoptosis of the HUVECs induced by H~2~O~2~. ^\#\#^P\<0.01 compared with the control group; ^\*\*^P\<0.01 compared with the H~2~O~2~ group. (D) Protein levels of LC3 and p62 or β-actin were determined by western blotting. Bar charts show the quantification of (E) LC3-II and (F) p62. (G) Protein levels of cytochrome *c* and cleaved caspase-3 or β-actin were determined by western blotting. Bar charts show the quantification of (H) cytochrome *c* and (I) cleaved caspase-3. The relative protein levels of cytochrome *c*, cleaved caspase-3, LC3-II and p62 are presented as the mean ± SEM of the optical density from three separate experiments. ^\#\#^P\<0.01 compared with the control group; ^\*^P\<0.05 and ^\*\*^P\<0.01 compared with the H~2~O~2~ group. HUVECs, human umbilical vein endothelial cells; Sal B, salvianolic acid B; 3-MA, 3-methyladenine; LC3, light chain 3; H~2~O~2~, hydrogen peroxide.
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![Sal B promotes the autophagy of HUVECs under oxidative stress. (A) Sal B promoted autophagic flux (magnification, ×200). (B) Quantitative bar charts of autophagy influx (C) HUVECs were treated with Sal B (5, 10 and 20 *µ*g/ml) for 24 h and the protein levels of LC3, p62 and Beclin-1 or β-actin were determined by western blotting. Bar charts show the quantification of (D) LC3-II, (E) Beclin-1 and (F) p62. The relative protein levels of LC3-II, p62 and Beclin-1 are presented as the mean ± SEM of the optical density from three separate experiments. ^\#^P\<0.05 and ^\#\#^P\<0.01 compared with the control group; ^\*\*^P\<0.01 compared with the H~2~O~2~ group. HUVECs, human umbilical vein endothelial cells; Sal B, salvianolic acid B; LC3, light chain 3; H~2~O~2~, hydrogen peroxide.](IJMM-44-02-0457-g06){#f5-ijmm-44-02-0457}

![Sal B promotes autophagy to decrease H~2~O~2~-induced apoptosis in HUVECs. (A) Sal B promoted the cell viability of HUVECs by H~2~O~2~ and 3-MA partly attenuated this. The results are expressed as the mean ± SEM of three independent experiments. ^\#\#^P\<0.01 compared with the control group; ^\*\*^P\<0.01 compared with the H~2~O~2~ group. (B) Flow cytometric analysis of HUVEC apoptosis stained with Annexin Ⅴ-FITC/propidium iodide double staining; (a) control group; (b) H~2~O~2~ group; (c) Sal B + H~2~O~2~ group; (d) Sal B + 3-MA group. (C) Rate of apoptotic cells quantified by flow cytometry; Sal B decreased apoptosis and 3-MA partly attenuated it. ^\#\#^P\<0.01 compared with the control group; ^\*\*^P\<0.01 compared with the H~2~O~2~ group. (D) HUVECs were treated with Sal B (5, 10 and 20 *µ*g/ml) for 24 h and the protein levels of LC3 or β-actin were determined by western blotting. Bar charts show the quantification of (E) LC3-II and (F) p62. The relative protein levels of LC3-II and p62 are presented as the mean ± SEM of the optical density from three separate experiments. (G) HUVECs were treated with Sal B (5, 10 and 20 *µ*g/ml) for 24 h and the protein level of cytochrome *c* cleaved caspase-3 was determined by western blotting. Quantification of (H) cleaved caspase-3 and (I) cytochrome *c* are presented as the mean ± SEM of three independent experiments, ^\#\#^P\<0.01 compared with the control group; ^\*\*^P\<0.01 compared with the H~2~O~2~ group. HUVECs, human umbilical vein endothelial cells; Sal B, salvianolic acid B; LC3, light chain 3; H~2~O~2~, hydrogen peroxide.](IJMM-44-02-0457-g07){#f6-ijmm-44-02-0457}

###### 

Sal B increases the protein expression of p-AMPK and decreases that of p-mTOR, resulting in a decreased rate of apoptosis, whereas compound C decreases the levels of p-AMPK and increases the rate of apoptosis. (A) Sal B mediated the protein expression of p-AMPK and p-mTOR, but did not affect p-AKT. Quantification of (B) p-AKT, (C) p-AMPK and (D) p-mTOR are expressed as the mean ± SEM of three independent experiments; ^\#^P\<0.05 and ^\#\#^P\<0.01 compared with the control group; ^\*\*^P\<0.01 compared with the H~2~O~2~ group. (E) Sal B increased the protein expression of p-AMPK and decreased that of p-mTOR, which was partly attenuated by compound C attenuated it partly. Quantification of (F) p-AMPK and (G) p-mTOR are presented as the mean ± SEM of three independent experiments. ^\#^P\<0.05 and ^\#\#^P\<0.01 compared with the control group; ^\*^P\<0.05 and ^\*\*^P\<0.01 compared with the H~2~O~2~ group. Sal B, salvianolic acid B; AMPK, AMP kinase; mTOR, mammalian target of rapamycin; p-, phosphorylated; H~2~O~2~, hydrogen peroxide.
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